<?xml version="1.0" encoding="UTF-8"?>
<p id="p0785" num="0785" sourceFile="EP 1828185B1.xml">The title compound was prepared from 
  <i>N</i>-{5-[3-(2-chloro-4-pyrimidinyl)pyrazolo[1,5-
  <i>a</i>]pyridin-2-yl]-2-fluorophenyl}-2,2,2-trifluoroacetamide (200 mg, 0.46 mmol) (
  <b>Example 160,</b> Step E) and 3-{[2-(dimethylamino)ethyl]oxy}aniline (123 mg, 0.57 mmol) using displacement conditions as described in 
  <b>Example 36, Step F</b> to generate the title compound in 77% yield (204 mg, 0.35 mmol). 
  <sup>1</sup>H NMR (400 MHz, d
  <sub>6</sub>-DMSO): δ 11.3 (bs, 1 H), 9.58 (s, 1 H), 8.84 (d, J = 6.9 Hz, 1 H), 8.49 (d, J = 9.0 Hz, 1 H), 8.30 (d, J = 5.3 Hz, 1 H), 7.82 (dd, J = 7.3, 2.2 Hz, 1 H), 7.44-7.52 (m, 4H), 7.28 (d, J = 8.9 Hz, 1 H), 7.14 (t, J = 7.9 Hz, 1 H), 6.52-6.55 (m, 2H), 4.00 (t, J = 5.7 Hz, 2H), 2.63 (t, J = 5.7 Hz, 2H), 2.21 (s, 6H). ES-LC/MS m/z = 580 [M+H]
  <sup>+</sup>.
</p>
